Germany
· Delayed Price · Currency is EUR BRAIN Biotech AG Company Description
BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom.
It operates through three segments: BioProducts, BioScience, and BioIncubator. The company offers enzymes, biocatalysts, microorganisms, and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production.
The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021.
The company was founded in 1993 and is headquartered in Zwingenberg, Germany.
| Country | Germany |
| Founded | 1993 |
| Industry | Specialty Chemicals |
| Sector | Materials |
| Employees | 318 |
| CEO | Adriaan Moelker |
Contact Details
Address: Darmstädter Strasse 34-36 Zwingenberg, 64673 Germany | |
| Phone | 49 62 51 9331 0 |
| Website | brain-biotech.com |
Stock Details
| Ticker Symbol | BNN |
| Exchange | Deutsche Börse Xetra |
| Fiscal Year | October - September |
| Reporting Currency | EUR |
| ISIN Number | DE0005203947 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Adriaan Moelker | Chairman of the Management Board and Chief Executive Officer |
| Ulrich Putsch | Co-Founder |
| Michael Schneiders | Chief Financial Officer and Member of Management Board |
| Dr. Ute Dechert | Vice President of Human Resources and Processes |
| Dr. Jurgen Eck | Consultant |
| Dr. Martin Langer | MD and Executive Vice President |
| Dr. Alexander Pelzer | Vice President and Head of Research and Development - Zwingenberg |
| Robbert Michael Hoekstra | Head of Group Finance |